Hyperhomocysteinemia, enzyme polymorphism and thiobarbituric acid reactive system in children with high coronary risk family history

Journal of the American College of Nutrition

Volumn 23, Issue 5, 2004, Pages 386-390

  Szamosi, Tamas ^a,c   Roth, Erzsebet ^b   Tomsits, Erika ^a   Tordai, Attila ^c   Szabo, Terez ^d  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b UNIVERSITY OF PÉCS   (Hungary)

^c National Health Center   (Hungary)

^d HEIM PÁL CHILDREN S HOSPITAL   (Hungary)

Author keywords

CHD; Children; Parents; Plasma TBARS; Plasma total homocysteine

Indexed keywords

5 FORMYLTETRAHYDROFOLATE CYCLOLIGASE; 5,10-METHENYLTETRAHYDROFOLATE SYNTHETASE; HOMOCYSTEINE; LIGASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADOLESCENT; ARTICLE; BLOOD; CASE CONTROL STUDY; CHILD; CORONARY ARTERY DISEASE; ENZYMOLOGY; FEMALE; FLUOROMETRY; GENETIC MARKER; GENETIC PREDISPOSITION; GENETICS; HUMAN; HYPERHOMOCYSTEINEMIA; MALE; METABOLISM; PRESCHOOL CHILD; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR;

ADOLESCENT; CARBON-NITROGEN LIGASES; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CORONARY DISEASE; FEMALE; FLUOROMETRY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RISK FACTORS; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 16644374369     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2004.10719382     Document Type: Article

References (27)

1. Williams CL, Hayman LL, Daniels SR, Robinson TN, Steinberger J, Paridon S, Bazzarre T: Cardiovascular health in childhood. A statement for health professionals from the Committee on Atherosclerosis, Hypertension and Obesity in the Young. Circulation 106:143–160, 2002.
2. Berenson GS, Srinivasan SR, Bao W, Newman WP, Tracy RE, Wattigney WA: Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. N Engl J Med 338:1650–1656, 1998.
3. Szamosi T, Murber A, Szamosi Jr T, Tory V, Kosztolicz Á, Sztankits K: Atherosclerosis risk factors in children of high risk families. Acta Physiol Hung 86:185–190, 1999.
4. Klausen IC, Beisiegel U, Menzel H-J, Rosseneu M, Nicaud V, Faergeman O: Apo(a) phenotypes and Lp(a) concentrations in offspring of men with and without myocardial infarction. Arterioscler Thromb Vasc Biol 15:1001–1008, 1995.
5. Islam S, Gutin B, Smith C, Treiber F, Kamboh MI: Association of apolipoprotein(a) phenotypes in children with family history of premature coronary artery disease. Atheroscler Thromb Vasc Biol 14:1609–1616, 1994.
6. Szamosi T, Hacsek G, Szamosi A, Popovits I, Venekei I, Javor A: Different cholesterol fractions, LCAT activity and lipid peroxides in the serum of children whose parents had early coronary heart disease. Clin Biochem. 21:97–99, 1988.
7. Nygard O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE: Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 337:230–236, 1997.
8. Duell PB, Malinow MR: Homocysteine: an important risk factor for atherosclerotic vascular disease. Cur Opin Lipidol 8:28–34, 1997.
9. Malinow MR: Plasma homocysteine and arterial occlusive diseases: A Mini-review. Clin Chem 40:173–176, 1994.
10. Kilmer S, McCully MD: Homocysteine, folate, vitamin B6, and cardiovascular disease. JAMA 279:392–393, 1998.
11. Siri PW, Verhoef P, KSok FJ: Vitamins B6, B12, and folate: association with plasma total homocysteine and risk of coronary atherosclerosis. J Am Coll Nutr 17:435–441, 1998.
12. Malinow MR, Nieto FJ, Kruger WD, Duell PB, Hess DL, Gluckman RA, Block PC, Holzgang CR, Anderson PH, Seltzer D, Upson B, Lin QR: The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetrahydrofolate reductase genotypes. Arterioscler Thromb Vasc Biol 17:1157–1162, 1997.
13. Anderson JL, King GJ, Thomson MJ, Todd M, Bair TL, Muhlestein RT, Carlquist JF: A mutation in the methylenetetrahydrofolate reductase gene is not associated with increased risk for coronary artery disease or myocardial infarction. J Am Coll Cardiol 30:1206–1211, 1997.
14. Chao CL, Tsai HH, Lee CM, Hsu SM, Kao JT, Chien KL, Sung FC, Lee YT: The graded effect of hyperhomocysteinemia on the severity and extent of coronary atherosclerosis. Atherosclerosis 147:379–386, 1999.
15. Margaglione M, Colaizzo D, Cappucci G, del Popolo A, Vecchione G, Grandone E, Di Minno G: Genetic polymorphism of 5, 10-MTHFR reductase gene in offspring of patients with myocardial infarction. Thromb Haemost 82:19–23, 1999.
16. Hirano K, Ogihara I, Miki M, Yasuda H, Kawamura N, Mino M: Homocysteine induces iron-catalyzed lipid peroxidation and susceptibility of low density lipoprotein that is prevented by alphatocopherol. Free Rad Res 21:267–276, 1994.
17. Yagi K: Assay for serum lipid peroxide level and its clinical significance. In Yagi K (ed): “Lipid Peroxides in Biology and Medicine.” New York: Academic Press, pp 223–242, 1982.
18. Friedewald WT, Levy RT, Fredrickson DS: Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of preparative ultracentrifuge. Clin Chem 18:499–502, 1972.
19. Frantzen F, Faaren AL, Alfheim I, Nordhei AK: Enzyme conversion immunoassay for determining total homocysteine in plasma or serum. Clin Chem 44:311–316, 1998.
20. Vilaseca MA, Moyano D, Ferrer I, Artuch R: Total homocysteine in pediatric patients. Clin Chem 43:690–692, 1997.
21. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJH, den Heijer M, Kluijtmans LAJ, van der Heuvel LP, Rozen R: A candidate risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111–113, 1995.
22. Berg K: Genetics of coronary heart disease. In Steinberg AG, Bearn AG, Motulsky AS (eds): “Progress in Medical Genetics,” vol 5. Philadelphia: Saunders Co, 1983.
23. Cavalca V, Cighetti G, Bamonti F, Loaldi A, Bortone L, Novembrino C, De Franceschi M, Belardinelli R, Guazzi MD: Oxidative stress and homocysteine in coronary artery disease. Clin Chem 47:887–892, 2001.
24. Draper H, Hadley M: Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol 186:421–431, 1990.
25. Haliwell B, Chirico S: Lipid peroxidation: its mechanism, measurement and significance. Am J Clin Nutr 57:715S–725S, 1993.
26. Berenson GS, McMahan CA, Voors AV, Webber LS, Srinivasan SR, Frank GC, Foster TA, Blonde CV: “Cardiovascular Risk Factors in Children—The Early Natural History of Atherosclerosis and Essential Hypertension.” New York: Oxford University Press, 1980.
27. Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, Graham I: Hyperhomocysteinemia an independent risk factor for vascular disease. N Engl J Med 324:1149–1155, 1991.